En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Sep 30, 2026 → Sep 30, 2028
See other at-risk trials from National Cancer Institute (NCI)

Record History

The 50 most recent of 292 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 30, 2026 to Sep 30, 2028
    • Study completion pushed from Sep 30, 2027 to Sep 30, 2029
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. New version filed on ClinicalTrials.gov
Show 45 earlier versionsHide 45 earlier versions
  1. 32 versions Re-verified since Sep 7, 2024, no change to tracked fieldsv256-v287
  2. Notable Primary completion date: Sep 30, 2025 to Sep 30, 2026
    • Study completion date: Sep 30, 2026 to Sep 30, 2027
    v255
  3. 4 versions Re-verified since Sep 30, 2023, no change to tracked fieldsv251-v254
  4. Notable Primary completion date: Sep 30, 2024 to Sep 30, 2025
    • Study completion date: Sep 30, 2025 to Sep 30, 2026
    v250
  5. 3 versions Re-verified since Feb 2, 2023, no change to tracked fieldsv247-v249
  6. Minor Interventions: TURBT (Procedure), modified resectoscope (Device)v246
  7. 2 versions Re-verified since Sep 17, 2022, no change to tracked fieldsv244-v245
  8. Notable Primary completion date: Sep 30, 2023 to Sep 30, 2024
    • Study completion date: Sep 30, 2024 to Sep 30, 2025
    v243
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Bladder cancer is the sixth most common cancer in the United States. The way that doctors remove tumors in bladder surgeries may leave some cancer . Also, many people have their tumors return or progress after surgery. Researchers want to test a modified device. It might tell doctors more about bladder tumors. Objective: To see if using a modified standard device with bladder surgery can provide better information about tumors in bladder specimens. Eligibility: People ages 18 and older who need to have their bladder removed at the NIH. Design: Participants will be screened with: Medical and prior surgical history Review of existing MRI, x-ray, or CT scans Review of existing specimens and reports Pregnancy test for women of childbearing age CT or MRI: Participants will lie in a machine. The machine will take pictures of their body. Participants will have bladder surgery. This will occur in the same way as if they did not take part in this study. A member of the research team will cut the removed bladder using the modified device. This will most likely be done on a separate back table in the operating room. The bladder and samples after cutting will be sent out for review. The will occur just as it would if the participants were not in this study. The only difference is the way that the specimen is prepared for review. Participants follow-up care will occur per standard of care. Or it will occur as part of any other study in which they might also be enrolled. ...
Trial Details
NCT Number NCT04235764
Lead Sponsor National Cancer Institute (NCI)
Conditions
(from sponsor)
Bladder Cancer
Related terms Urinary Bladder Neoplasms
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov